Connect with us

Healthcare

‘It’s Going To Be Very Disturbing’: Fauci Says COVID Cases Could Surge By 100,000 A Day

Published

on

anthony fauci deborah

In his Tuesday testimony before members of Congress, infectious disease expert Dr. Anthony Fauci spoke about his concerns over certain states’ reopening plans and the surge of cases the nation has seen in past days. He noted the death totals will be concerning and the country is “going in the wrong direction.”

Before the Senate Health, Education, Labor and Pensions committee, Fauci fielded questions from senators — one question covered new data showing a 40,000 increase in cases one day last week. He said that “we’re not in control” and it would come at no surprise to him if the nation saw an increase by 100,000 cases in one day.

“The numbers speak for themselves,” Fauci testified. “I’m very concerned. I’m not satisfied with what’s going on because we’re going in the wrong direction.”

According to the Guardian, Fauci called out younger Americans to follow guidelines.

“What we saw were a lot of people who maybe felt because they think they are invulnerable – and we know many young people are not because they’re getting serious disease – that therefore their getting infected has nothing to do with anyone else,” Fauci said.

Fauci urged the public to follow CDC and local guidelines, including the wearing of a mask in public and maintaining six feet distance from others.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Healthcare

Supreme Court rules anti-abortion doctors lack standing to sue FDA

Published

on

Supreme Court

In a unanimous decision on Thursday, the Supreme Court ruled that the anti-abortion doctors who challenged the Food and Drug Administration’s (FDA) approval of the abortion pill mifepristone lack the standing to sue the federal agency. This ruling preserves the FDA’s existing approval of the drug.

The opinion, authored by Justice Brett Kavanaugh, emphasized that the plaintiffs presented “several complicated causation theories to connect FDA’s actions to the plaintiffs’ alleged injuries in fact.” However, none of these theories were sufficient to establish Article III standing, which requires a personal stake in the dispute.

National Review reports the lawsuit was filed in November 2022 by the Alliance Defending Freedom (ADF) on behalf of the Alliance for Hippocratic Medicine and four pro-life doctors. The plaintiffs claimed that the FDA had no authority to approve the two-pill chemical-abortion regimen under Subpart H, a federal code section allowing expedited approval for drugs treating “serious or life-threatening illnesses.” They argued that pregnancy is not an illness but a normal physiological state.

The plaintiffs also challenged the FDA’s 2016 and 2021 decisions to relax restrictions on mifepristone, such as increasing the gestational age for its use, reducing required office visits, allowing non-doctors to prescribe the pills, and permitting mail delivery during the COVID-19 pandemic.

Abortion opponents expressed disappointment with the decision. Erin Hawley, a lawyer with ADF, criticized the FDA for allegedly endangering women by allowing the use of mifepristone without in-person medical supervision. Ingrid Skop from the Charlotte Lozier Institute and Katie Daniel from Susan B. Anthony Pro-Life America echoed similar sentiments, stressing their concerns about the safety of mail-order abortion drugs.

President Joe Biden, however, applauded the decision, highlighting the ongoing risks to women’s rights to necessary medical treatment in many states.

Justice Kavanaugh’s opinion stated that the plaintiffs did not demonstrate a direct injury that would force them to participate in abortion procedures against their conscience. He added that concerns about the potential for increased emergency room visits did not justify legal standing.

Kavanaugh noted that doctors and citizens opposed to FDA regulations should seek changes through legislative and executive branches rather than the courts. This decision aligns with a previous lower court ruling that found the legal challenge was filed too late, beyond the statute of limitations.

Earlier this year, U.S. District Judge Matthew Kacsmaryk in Texas ruled in favor of the plaintiffs, suspending the FDA’s approval of mifepristone. This decision was subsequently overturned by the Fifth Circuit Court of Appeals, which restored access to the drug. The Supreme Court’s stay ensured that the drug remained available while legal proceedings continued.

Democratic lawmakers welcomed the Supreme Court’s ruling. Congresswoman Ayanna Pressley described it as a “major relief & victory for anyone who has ever or will ever need essential medication abortion care.” Senator Elizabeth Warren criticized the challenge as baseless and underscored the safety and effectiveness of chemical-abortion pills. She warned of ongoing efforts by Republicans to impose a nationwide abortion ban and called for continued protection of reproductive freedom.

 

Continue Reading

Trending